GPR52 and Huntington disease: Among them, GPR52 is an orphan GPCR exclusively expressed in the brain, especially in the striatum (Komatsu et al., 2014), and represents a potential therapeutic target for HD (Komatsu, 2021; Wang et al., 2021).